Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acne-ID: low-dose versus standard-dose isotretinoin for severe acne in young people
ISRCTN45540647Phase 4Recruiting
- Sponsor
- University of Nottingham
- Start
- Dec 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of isotretinoin in acne vulgaris (2 arms), sponsored by University of Nottingham. Started Dec 2024; status: recruiting.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ISRCTN45540647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN45540647.